secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001213900-26-024339
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics obtains $20M debt financing from Streeterville Capital with $20.93M notes
--------------------------------------------------------------------------------

- Issued $10.93M A-1 Note (9% interest) and $10M secured B Note (5% interest) for $20M purchase price.
- $900K OID and $30K expense included; maturity 18 months from March 2, 2026.
- B Note secured by $10M deposit account and pledge of ALLR Holdings LLC; guaranteed by three subsidiaries.
- Covenants restrict additional debt, variable-rate issuances, and asset encumbrances without lender consent.
- Investor can redeem up to $250K/month starting 6 months after closing; trigger events allow 10%/5% balance increases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390026024339/0001213900-26-024339-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390026024339/ea0279478-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-024339

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer